| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35149-10ug | |||
| Carrier-Free | NBP2-35149-1000ug | |||
| Carrier-Free | NBP2-35149-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34924-10ug | |||
| Carrier-Free | NBP2-34924-1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12021-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35112-1mg | |||
| Carrier-Free | NBP2-35112-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35113-10ug | |||
| Carrier-Free | NBP2-35113-1mg | |||
| Carrier-Free | NBP2-35113-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34909-10ug | |||
| Carrier-Free | NBP2-34909-1mg | |||
| Carrier-Free | NBP2-34909-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34911-1mg | |||
| Carrier-Free | NBP2-34911-100ug | |||
| Carrier-Free | NBP2-34911-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35254-10ug | |||
| Carrier-Free | NBP2-35254-1mg | |||
| Carrier-Free | NBP2-35254-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35257-10ug | |||
| Carrier-Free | NBP2-35257-1mg | |||
| Carrier-Free | NBP2-35257-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34897-10ug | |||
| Carrier-Free | NBP2-34897-1mg | |||
| Carrier-Free | NBP2-34897-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81082-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81120-0.025mg | |||
![SDS-Page: Human KGF/FGF-7 Protein [NBP2-34924]](http://images.novusbio.com/fullsize/Human-KGF-FGF-7-Protein-SDS-Page-NBP2-34924-img0002.jpg "SDS-Page: Human KGF/FGF-7 Protein [NBP2-34924]")
![Flow Cytometry: IL-9 Antibody (D9302C12) - Chimeric [NBP3-12021] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of D9302C12 (NBP3-12021, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/IL-9-Antibody-D9302C12-Chimeric-Flow-Cytometry-NBP3-12021-img0001.jpg "Flow Cytometry: IL-9 Antibody (D9302C12) - Chimeric [NBP3-12021] - Mouse splenocytes were stimulated with PMA and Ionomycin in presence of Monensin for 4 hours. The cells were fixed using 2% PFA, permeabilized using 0.5% Triton and stained with anti-Fluorescein IgG antibody (4-4-20; isotype control, black line) or the rabbit IgG version of D9302C12 (NBP3-12021, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-mouse IgG AlexaFluor(R) 488 antibody at a dilution of 1:1000 and cells were analyzed using a FACSCanto flow-cytometer.")
![SDS-Page: Mouse Oncostatin M/OSM Protein [NBP2-35112]](http://images.novusbio.com/fullsize/Mouse-Oncostatin-M-OSM-Protein-SDS-Page-NBP2-35112-img0001.jpg "SDS-Page: Mouse Oncostatin M/OSM Protein [NBP2-35112]")
![SDS-Page: Human Oncostatin M/OSM Protein [NBP2-35113]](http://images.novusbio.com/fullsize/Human-Oncostatin-M-OSM-Protein-SDS-Page-NBP2-35113-img0001.jpg "SDS-Page: Human Oncostatin M/OSM Protein [NBP2-35113]")
![SDS-Page: Human IL-9 Protein [NBP2-34909]](http://images.novusbio.com/fullsize/Human-IL-9-Protein-SDS-Page-NBP2-34909-img0001.jpg "SDS-Page: Human IL-9 Protein [NBP2-34909]")
![SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]](http://images.novusbio.com/fullsize/Human-CXCL10-IP-10-CRG-2-Protein-SDS-Page-NBP2-34911-img0001.jpg "SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]")
![SDS-Page: Rat IL-6 Protein [NBP2-35254]](http://images.novusbio.com/fullsize/Rat-IL-6-Protein-SDS-Page-NBP2-35254-img0001.jpg "SDS-Page: Rat IL-6 Protein [NBP2-35254]")
![SDS-Page: Rat IL-9 Protein [NBP2-35257]](http://images.novusbio.com/fullsize/Rat-IL-9-Protein-SDS-Page-NBP2-35257-img0001.jpg "SDS-Page: Rat IL-9 Protein [NBP2-35257]")
![SDS-Page: Human IL-5 Protein [NBP2-34897]](http://images.novusbio.com/fullsize/Human-IL-5-Protein-SDS-Page-NBP2-34897-img0002.jpg "SDS-Page: Human IL-5 Protein [NBP2-34897]")
![Flow Cytometry: TGF-alpha Antibody (tAb2) [NBP2-81082] - Flow-cytometry using the [NBP2-81082]. Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of tAb2 (NBP2-81082, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/TGF-alpha-Antibody-tAb2-Flow-Cytometry-NBP2-81082-img0001.jpg "Flow Cytometry: TGF-alpha Antibody (tAb2) [NBP2-81082] - Flow-cytometry using the [NBP2-81082]. Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of tAb2 (NBP2-81082, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")